Literature DB >> 27799344

Autotransplants in older multiple myeloma patients: hype or hope in the era of novel agents?

Monika Engelhardt1, Gabriele Ihorst2, Jo Caers3, Andreas Günther4, Ralph Wäsch5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27799344      PMCID： PMC5394867          DOI： 10.3324/haematol.2016.154807

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Transplants for the elderly in myeloma.

Authors:  Gareth J Morgan
Journal:  Blood       Date:  2013-08-22       Impact factor: 22.113

Review 2.  European perspective on multiple myeloma treatment strategies in 2014.

Authors:  Heinz Ludwig; Pieter Sonneveld; Faith Davies; Joan Bladé; Mario Boccadoro; Michele Cavo; Gareth Morgan; Javier de la Rubia; Michel Delforge; Meletios Dimopoulos; Hermann Einsele; Thierry Facon; Hartmut Goldschmidt; Philippe Moreau; Hareth Nahi; Torben Plesner; Jesús San-Miguel; Roman Hajek; Pia Sondergeld; Antonio Palumbo
Journal:  Oncologist       Date:  2014-07-25

Review 3.  The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.

Authors:  Jo Caers; Carlos Fernández de Larrea; Xavier Leleu; Roy Heusschen; Niklas Zojer; Olivier Decaux; Efstathios Kastritis; Monique Minnema; Artur Jurczyszyn; Yves Beguin; Ralph Wäsch; Antonio Palumbo; Meletios Dimopoulos; Maria Victoria Mateos; Heinz Ludwig; Monika Engelhardt
Journal:  Oncologist       Date:  2016-02-26

4.  Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.

Authors:  Monika Engelhardt; Sandra Maria Dold; Gabriele Ihorst; Alexander Zober; Mandy Möller; Heike Reinhardt; Stefanie Hieke; Martin Schumacher; Ralph Wäsch
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

5.  Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.

Authors:  Gareth J Morgan; Faith E Davies; Walter M Gregory; Nigel H Russell; Sue E Bell; Alexander J Szubert; Nuria Navarro Coy; Gordon Cook; Sylvia Feyler; Jenny L Byrne; Huw Roddie; Claudius Rudin; Mark T Drayson; Roger G Owen; Fiona M Ross; Graham H Jackson; J Anthony Child
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

6.  Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.

Authors:  H W Auner; R Szydlo; J Hoek; H Goldschmidt; A M Stoppa; G J Morgan; P Moreau; M Attal; G Marit; N Russell; M Brune; G Cook; P Sonneveld; S Schönland; L Garderet; N Kröger
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

7.  Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Authors:  Michele Cavo; Lucia Pantani; Maria Teresa Petrucci; Francesca Patriarca; Elena Zamagni; Daniela Donnarumma; Claudia Crippa; Mario Boccadoro; Giulia Perrone; Antonietta Falcone; Chiara Nozzoli; Renato Zambello; Luciano Masini; Anna Furlan; Annamaria Brioli; Daniele Derudas; Stelvio Ballanti; Maria Laura Dessanti; Valerio De Stefano; Angelo Michele Carella; Magda Marcatti; Andrea Nozza; Felicetto Ferrara; Vincenzo Callea; Catello Califano; Annalisa Pezzi; Anna Baraldi; Mariella Grasso; Pellegrino Musto; Antonio Palumbo
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

8.  Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.

Authors:  Christian Straka; Peter Liebisch; Hans Salwender; Burkhard Hennemann; Bernd Metzner; Stefan Knop; Sigrid Adler-Reichel; Christian Gerecke; Hannes Wandt; Martin Bentz; Tim Hendrik Bruemmendorf; Marcus Hentrich; Michael Pfreundschuh; Hans-Heinrich Wolf; Orhan Sezer; Ralf Bargou; Wolfram Jung; Lorenz Trümper; Bernd Hertenstein; Else Heidemann; Helga Bernhard; Nicola Lang; Norbert Frickhofen; Holger Hebart; Ralf Schmidmaier; Andreas Sandermann; Tobias Dechow; Albrecht Reichle; Brigitte Schnabel; Kerstin Schäfer-Eckart; Christian Langer; Martin Gramatzki; Axel Hinke; Bertold Emmerich; Hermann Einsele
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

9.  Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.

Authors:  Laurent Garderet; Eric Beohou; Denis Caillot; Anne Marie Stoppa; Cyrille Touzeau; Marie Lorraine Chretien; Lionel Karlin; Philippe Moreau; Jean Fontan; Didier Blaise; Emmanuelle Polge; Mor Seny Gueye; Souhila Ikhlef; Zora Marjanovic; Myriam Labopin; Mohamad Mohty
Journal:  Haematologica       Date:  2016-09-09       Impact factor: 9.941

10.  European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Authors:  Monika Engelhardt; Evangelos Terpos; Martina Kleber; Francesca Gay; Ralph Wäsch; Gareth Morgan; Michele Cavo; Niels van de Donk; Andreas Beilhack; Benedetto Bruno; Hans Erik Johnsen; Roman Hajek; Christoph Driessen; Heinz Ludwig; Meral Beksac; Mario Boccadoro; Christian Straka; Sara Brighen; Martin Gramatzki; Alessandra Larocca; Henk Lokhorst; Valeria Magarotto; Fortunato Morabito; Meletios A Dimopoulos; Hermann Einsele; Pieter Sonneveld; Antonio Palumbo
Journal:  Haematologica       Date:  2014-02       Impact factor: 9.941
View more
  4 in total

1.  Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.

Authors:  Matthias Naegele; Monika Kirsch; Gabriele Ihorst; Katharina Fierz; Monika Engelhardt; Sabina De Geest
Journal:  Support Care Cancer       Date:  2017-09-16       Impact factor: 3.603

2.  A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.

Authors:  Monika Engelhardt; Anne-Saskia Domm; Sandra Maria Dold; Gabriele Ihorst; Heike Reinhardt; Alexander Zober; Stefanie Hieke; Corine Baayen; Stefan Jürgen Müller; Hermann Einsele; Pieter Sonneveld; Ola Landgren; Martin Schumacher; Ralph Wäsch
Journal:  Haematologica       Date:  2017-02-02       Impact factor: 9.941

Review 3.  From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.

Authors:  Francesca Gay; Monika Engelhardt; Evangelos Terpos; Ralph Wäsch; Luisa Giaccone; Holger W Auner; Jo Caers; Martin Gramatzki; Niels van de Donk; Stefania Oliva; Elena Zamagni; Laurent Garderet; Christian Straka; Roman Hajek; Heinz Ludwig; Herman Einsele; Meletios Dimopoulos; Mario Boccadoro; Nicolaus Kröger; Michele Cavo; Hartmut Goldschmidt; Benedetto Bruno; Pieter Sonneveld
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941

4.  Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.

Authors:  Holger W Auner; Simona Iacobelli; Giulia Sbianchi; Cora Knol-Bout; Didier Blaise; Nigel H Russell; Jane F Apperley; David Pohlreich; Paul V Browne; Guido Kobbe; Cecilia Isaksson; Stig Lenhoff; Christof Scheid; Cyrille Touzeau; Esa Jantunen; Achilles Anagnostopoulos; Ibrahim Yakoub-Agha; Alina Tanase; Nicolaas Schaap; Wieslaw Wiktor-Jedrzejczak; Marta Krejci; Stefan O Schönland; Curly Morris; Laurent Garderet; Nicolaus Kröger
Journal:  Haematologica       Date:  2017-12-07       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.